Erlanger Neurology Receives $75,000 from ALS Association

Left to Right: Ashley Evans, Dr. Chelsea Shugars, Dr. Josh Alpers CHATTANOOGA, TENN. – On February 20, Erlanger Neurology was presented with a $75,000 check from the ALS Association. ALS (Amyotrophic lateral sclerosis) is a fatal and progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. The ALS Association is …

Erlanger Baroness Hospital is nationally recognized for tenth time as Gold Plus for commitment to high-quality stroke care by American Heart and Stroke Associations

Chattanooga, Tenn. – Erlanger Baroness Hospital has been recognized by the American Heart Association and the American Stroke Association’s “Get with the Guidelines” program as a Gold Plus organization for the tenth time as well as the third consecutive year to be recognized with “Honor Roll Elite Plus, Advanced Therapy and Target: Type 2 Diabetes …

Erlanger Baroness recognized as Gold Plus by American Heart Association and American Stroke Association for Stroke program

Chattanooga, Tenn. – Erlanger Baroness Hospital is recognized by the American Heart Association and the American Stroke Association’s “Get with the Guidelines” program as a Gold Plus organization for the sixth year in a row as well as the second consecutive year to be recognized with “Honor Roll Elite Plus, Advanced Therapy and Target: Type …

Erlanger welcomes two specialty medical directors

Dr. Mounzer Yassin-Kassab Medical Director of Erlanger Neurology Chattanooga, Tenn. – Erlanger Medical Group welcomes two new medical directors to its growing list of providers – Dr. Mounzer Yassin-Kassab, as Medical Director of Erlanger Neurology, and Dr. Juan Cuebas, as Medical Director of the Erlanger Sleep Disorders Center. Mounzer Yassin-Kassab, MD, MA, is board-certified in …